Loading company…
Nanological develops diagnostic devices, including a rapid test for sepsis.
Founded in 2021 in Spain, Nanological develops medical devices using optics, nanomechanics and machine learning. Its diagnostic technology is designed to detect pathogens associated with sepsis. The company spun out of the Spanish National Research Council and raised EUR 600,000 in November 2023 in funding led by Clave Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in